Zosano Pharma Overview
- Year Founded
-
2006
- Status
-
Acquired/Merged
- Employees
-
40
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$1M
- Investors
-
1
Zosano Pharma General Information
Description
Operator of a biopharmaceutical firm intended to acquire, develop and bring to market less toxic and effective therapies to treat and cure migraine. The company specializes in providing rapid systemic administration of therapeutics and other bioactive molecules to patients using the proprietary transdermal microneedle system.
Contact Information
Website
www.zosanopharma.comCorporate Office
- 34790 Ardentech Court
- Fremont, CA 94555
- United States
Corporate Office
- 34790 Ardentech Court
- Fremont, CA 94555
- United States
Zosano Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 16. Merger/Acquisition | 25-Aug-2022 | $1M | Completed | Generating Revenue | ||
| 15. Bankruptcy: Admin/Reorg | 01-Jun-2022 | Completed | Bankruptcy: Admin/Reorg | |||
| 14. PIPE | Completed | Clinical Trials - General | ||||
| 13. 2PO | 29-Mar-2018 | Completed | Clinical Trials - General | |||
| 12. PIPE | 20-Oct-2017 | Completed | Generating Revenue | |||
| 11. Secondary Transaction - Open Market | 19-Apr-2017 | Completed | Generating Revenue | |||
| 10. Secondary Transaction - Open Market | 05-Jan-2017 | Completed | Generating Revenue | |||
| 9. Secondary Transaction - Open Market | 01-Oct-2016 | Completed | Generating Revenue | |||
| 8. PIPE | 01-Aug-2016 | $185M | Completed | Generating Revenue | ||
| 7. PIPE | 30-Jan-2015 | $15M | $185M | Completed | Clinical Trials - Phase 1 |
Zosano Pharma Comparisons
Industry
Financing
Details
Zosano Pharma Competitors (16)
One of Zosano Pharma’s 16 competitors is BioDelivery Sciences International, a Private Equity-Backed company based in Raleigh, NC.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioDelivery Sciences International | Private Equity-Backed | Raleigh, NC | ||||
| Prosolus | Venture Capital-Backed | Miami, FL | ||||
| Corium International | Private Equity-Backed | Cambridge, MA | ||||
| Medherant | Venture Capital-Backed | Coventry, United Kingdom | ||||
| Cerecin | Venture Capital-Backed | Broomfield, CO |
Zosano Pharma Patents
Zosano Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021222885-A1 | Transdermal drug delivery devices having psilocybin, lysergic acid diethylamide or 3,4-methylenedioxymethamphetamine coated microprotrusions | Inactive | 01-May-2020 | ||
| WO-2021216925-A1 | Transdermal active agent delivery devices having coronavirus vaccine coated microprotrusions | Inactive | 22-Apr-2020 | ||
| JP-2021500397-A | How to quickly obtain zolmitriptan therapeutic concentrations suitable for the treatment of migraine and cluster headaches | Active | 23-Aug-2017 | ||
| AU-2017428907-A1 | Method of rapidly achieving therapeutic concentrations of zolmitriptan for treatment of migraines and cluster headaches | Active | 23-Aug-2017 | ||
| AU-2017428907-B2 | Method of rapidly achieving therapeutic concentrations of zolmitriptan for treatment of migraines and cluster headaches | Inactive | 23-Aug-2017 | A61K9/0021 |
Zosano Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Zosano Pharma Former Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aisling Capital | Venture Capital | Minority | ||
| Amzak Capital Management | Family Office | Minority | ||
| Amzak Health | Venture Capital | Minority | ||
| BioMed Realty | Real Estate | Minority | ||
| BioMed Ventures | Corporate Venture Capital | Minority |
Zosano Pharma Acquisitions (1)
Zosano Pharma’s most recent deal was a Merger/Acquisition with JEM Capital. The deal was made on 01-Oct-2013.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| JEM Capital | 01-Oct-2013 | Merger/Acquisition | Specialized Finance |
Zosano Pharma FAQs
-
When was Zosano Pharma founded?
Zosano Pharma was founded in 2006.
-
Where is Zosano Pharma headquartered?
Zosano Pharma is headquartered in Fremont, CA.
-
What is the size of Zosano Pharma?
Zosano Pharma has 40 total employees.
-
What industry is Zosano Pharma in?
Zosano Pharma’s primary industry is Drug Delivery.
-
Is Zosano Pharma a private or public company?
Zosano Pharma is a Private company.
-
What is the current valuation of Zosano Pharma?
The current valuation of Zosano Pharma is .
-
What is Zosano Pharma’s current revenue?
The current revenue for Zosano Pharma is .
-
How much funding has Zosano Pharma raised over time?
Zosano Pharma has raised $284M.
-
Who are Zosano Pharma’s investors?
Aisling Capital, Amzak Capital Management, Amzak Health, BioMed Realty, and BioMed Ventures are 5 of 14 investors who have invested in Zosano Pharma.
-
Who are Zosano Pharma’s competitors?
BioDelivery Sciences International, Prosolus, Corium International, Medherant, and Cerecin are some of the 16 competitors of Zosano Pharma.
-
When was Zosano Pharma acquired?
Zosano Pharma was acquired on 25-Aug-2022.
-
Who acquired Zosano Pharma?
Zosano Pharma was acquired by Gylden Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
